IGF-1 LR3 is a modified analogue of insulin-like growth factor 1 used in laboratory research. Structural modifications are intended to alter interactions with IGF-binding proteins and extend experimental activity compared with native IGF-1.
Research areas
IGF-1 receptor signaling.
Cell growth and differentiation pathways.
Laboratory models of IGF-related biology.
Evidence context
IGF-1 LR3 is an experimental research reagent and should not be presented as an approved therapeutic product.
For research purposes only. Not intended for human consumption, self-administration or use as a medicine.
